Can a common cholesterol pill shield hearts from chemo damage?
NCT ID NCT07254221
Summary
This study is testing whether the drug rosuvastatin can protect the heart from damage caused by a common type of breast cancer chemotherapy. 400 women starting this chemotherapy will take either rosuvastatin or a placebo pill daily for one year. The main goal is to see if the drug can prevent a drop in the heart's pumping strength, a known side effect of the cancer treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kowsar Hospital, Fars Heart Foundation
Shiraz, Fars, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Modarres Hospital, Shahid Beheshti University of Medical Sciences
Tehran, Tehran Province, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Motahari Breast Cancer Clinic
Shiraz, Fars, 71344-1864, Iran
Contact Email: •••••@•••••
-
Rajaee Hospital, Iran University of Medical Sciences
Tehran, Tehran Province, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sina Hospital, Tehran University of Medical Sciences
Tehran, Tehran Province, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Taleghani Hospital, Shahid Beheshti University of Medical Sciences
Tehran, Tehran Province, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Toba Oncology Department, Mazandaran University of Medical Sciences
Sari, Mazandaran, Iran
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.